ProMIS Neurosciences, Inc.
PMN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13,291 | $12,598 | $7,956 | $21,426 |
| Short-Term Investments | $33 | $32 | $59 | $51 |
| Receivables | $78 | $79 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5,509 | $910 | $1,332 | $924 |
| Total Curr. Assets | $18,911 | $13,619 | $9,347 | $22,400 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $6 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $28 | $35 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$0 | -$0 |
| Total NC Assets | $0 | $0 | $29 | $41 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $18,911 | $13,619 | $9,376 | $22,441 |
| Liabilities | – | – | – | – |
| Payables | $1,737 | $7,843 | $4,029 | $517 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $481 | $1,507 | $4,654 | $658 |
| Total Curr. Liab. | $2,218 | $9,350 | $8,683 | $1,175 |
| LT Debt | $0 | $0 | $0 | $4,939 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $205 | $516 | $2,517 | $9,170 |
| Total NC Liab. | $205 | $516 | $2,517 | $14,109 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,423 | $9,866 | $11,200 | $15,284 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$90,687 | -$93,466 | -$108,659 | -$78,643 |
| AOCI | -$371 | -$371 | -$265 | -$238 |
| Other Equity | $107,546 | $97,590 | $107,099 | $86,038 |
| Total Equity | $16,488 | $3,753 | -$1,825 | $7,157 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $18,911 | $13,619 | $9,376 | $22,441 |
| Net Debt | -$13,291 | -$12,598 | -$7,956 | -$16,487 |